BENJAMIN QUAGLIA
Primary Packaging Development Manager, Laboratoires Théa, Clermont-Ferrand, France

Abstract

The global market for ophthalmic eye droppers is expected to grow due to the rising rates of eye diseases such as glaucoma, dry eye disease, and age-related macular degeneration. Various packaging advancements for eye drops have occurred over time. Currently, manufacturers are exploring multidose bottles that safely dispense unpreserved drops without contamination. Regulatory approvals for these products have become more common, emphasizing the importance of maintaining sterility. There are opportunities for innovation, particularly in eco-design, focusing on reducing plastic use and water consumption; and in digital technology, utilizing sensors, AI and telemedicine to improve patient adherence and care.
Future innovations may include alternative delivery methods to improve treatment efficacy and management of eye diseases. This article aims to discuss the Ophthalmic Drug Delivery Latest Development.

The global ophthalmic eyedropper market is expected to grow due to the increasing prevalence of eye diseases like glaucoma, dry eye disease, and age-related macular degeneration. The aging population is a key factor driving this growth, as older individuals are more likely to experience these eye conditions (1).
Glaucoma, especially open-angle glaucoma, is the leading cause of irreversible blindness (2) and often requires eye drops to manage intraocular pressure.

With the elderly being six times more likely to develop glaucoma after age 60 (3), the demand for glaucoma eye drops is likely to rise. The dry eye category had the highest revenue in 2023, influenced by the frequent use of digital screens (4) and other factors like aging and pollution. Artificial tears are the main treatment for dry eye symptoms. As the market expands, manufacturers must focus on understanding and addressing patient challenges related to administering eye drops and improving home eye care management.

Historically, ointments were preferred, being easier to manufacture and less contaminable. The main problem for manufacturers was the production of solutions capable ...